Gareth Gacetta

Sep 10, 2026

Gareth Gacetta rated UPXI as Overweight on Sep 10, 2026, setting a price target of 2. Shares have remained stable near 0.9937, leaving the 2 target still in play.

Sep 10, 2026

On Sep 10, 2026, STKE was given a Overweight rating by Gareth Gacetta, with a target price of 6.2. The stock traded sideways with a 0.00% move, keeping the bullish thesis unresolved.

Sep 10, 2026

SUIG received a Overweight rating from Gareth Gacetta on Sep 10, 2026, aiming for 3.4. Price action was muted, as shares hovered around 0.9846 despite the bullish outlook.

Sep 10, 2026

On Sep 10, 2026, Gareth Gacetta published a Overweight outlook on DFDV, with a target of 10.4. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 5.17.

Sep 10, 2026

Gareth Gacetta on Sep 10, 2026 assigned FWDI a Overweight rating, with a price target of 16. The recommendation remains pending validation as shares consolidate around 6.46.

Sep 10, 2026

On Sep 10, 2026, Gareth Gacetta reaffirmed HYPD with a Overweight rating, targeting 11.2. Market indecision has kept the 11.2 target in a holding pattern.

Sep 10, 2026

PURR was rated Overweight by Gareth Gacetta on Sep 10, 2026, with a price objective of 34.2. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

Sep 10, 2026

On Sep 10, 2026, Gareth Gacetta initiated coverage on SBET with a Overweight rating and target of 17. Neutral price movement of 0.00% leaves room for interpretation.

Jul 01, 2026

Gareth Gacetta issued a Overweight recommendation for CYPH on Jul 01, 2026, price target set at 0.9. Investors following the Buy call captured upside momentum, with shares now at 2.2.

Jul 01, 2026

On Jul 01, 2026, BMNR was evaluated by Gareth Gacetta, who gave a Overweight rating and target of 30.3. This case illustrates how a timely bullish rating can translate into tangible gains of 71.02%.